|
|
||||||||
Address correspondence to Soo Hwan Pai, M.D., Department of Clinical Pathology, Inha University Hospital, 7-206, 3-ga, Shinheung-dong, Jung-gu, Inchon, 400-103, South Korea; tel 82 32 890 2502; fax 82 32 890 2529; e-mail shpaimd{at}inha.ac.kr.
| Abstract |
|---|
|
|
|---|
14.0 g/dL (170 ± 17 mg/dL) (p <0.01). Moreover, serum triglyceride concentration in subjects with blood Hb >14.0 g/dL was 2-fold higher than in the severely anemic subjects. Mean values of serum total cholesterol and triglyceride (149 ± 17 mg/dL and 58 ± 22 mg/dL) in girls with severe anemia were significantly elevated after iron supplementation (164 ± 17 mg/dL and 98 ± 26 mg/dL) (p <0.01, respectively). In the severely anemic subjects, blood Hb concentration was correlated with serum total cholesterol (r = 0.49, p <0.01) and triglyceride concentrations (r = 0.51, p <0.01). These findings indicate that severe iron deficiency anemia in girls is attended by decreased concentrations of serum total cholesterol and triglyceride, and that these reduced serum lipid levels return to normal following iron supplementation. (received 7 November 2000; accepted 30 November 2000)
Keywords: iron deficiency, iron supplementation, serum cholesterol, serum triglyceride, serum lipid profiles
| Introduction |
|---|
|
|
|---|
Iron is an essential metal involved in a wide spectrum of physiological functions in the body, such as oxygen transport and enzymatic reactions. Nevertheless, excess iron can be harmful because it promotes the generation of free radicals, which lead to tissue damage [1,3]. Iron deficiency is commonly encountered in young infants and adolescent girls. The progressive stages of iron deficiency during a period of negative iron balance include iron depletion (stage I), iron deficient erythropoiesis (stage II), and iron deficiency anemia (stage III). During the iron depletion phase, tissue iron stores are exhausted, but neither anemia nor decreased serum iron concentration is evident. In the iron deficient stage, erythropoiesis, serum iron, and serum ferritin levels are decreased, but anemia and hypochromia are still not apparent [4].
In an epidemiological study, high body iron stores were related to an increased risk of coronary heart disease [5]. Subsequent studies have shown that low serum iron-binding capacity and high serum iron concentrations are risk factors for myocardial infarction [6,7]. Although associations have been found between dietary iron intake and serum lipid and lipoprotein concentrations in animal models [8,9], such relationships have not been investigated extensively in humans, and the available data are inconsistent. Knowledge about the effect of iron deficiency on serum lipid profiles is limited. Therefore, in the present study, we investigated the changes in serum lipid concentrations that occur during progressive stages of iron depletion and after iron supplementation.
| Materials and Methods |
|---|
|
|
|---|
The subjects were all South Korean students from middle-class families; there were no significant differences in racial composition or socioeconomic status among the groups. This study was explained to and approved by the subjects parents and by the academic administrators at each educational center, and only volunteers were included in the study population. The study was approved by the Committee of Ethics of the Inha University Hospital, and informed consent was obtained from all subjects.
The subjects were divided into 4 groups: iron depletion phase (n = 102), iron deficient erythropoiesis (n = 73), iron deficiency anemia (n = 115), and healthy controls (n = 137). Non-anemic subjects with normal serum iron level (>50 µg/dL) but decreased ferritin concentration (<12 µg/L) were classified as being in the iron depletion phase. Iron deficient erythropoiesis was defined as the presence of serum ferritin concentration <12 µg/L and serum iron level <50 µg/ dL without overt anemia. When subjects with decreased serum ferritin concentration and decreased serum iron level also had decreased blood hemoglobin level (<12.0 g/dL), they were considered to have iron deficiency anemia. We assigned subjects with blood hemoglobin <8.0 g/dL to the severely anemic group and compared their serum lipid levels with those of subjects with hemoglobin >14.0 g/dL.
To investigate the effect of iron supplementation on serum lipid concentrations, 52 girls with hemoglobin <8.0 g/dL were supplemented with one 256 mg tablet of ferrous sulfate (80 mg of elemental iron) per day for 3 mo; however, vitamin B12 or folate was not supplemented. The compliance for iron supplementation was checked by interviews throughout the period of treatment; blood samples were obtained from 41 of these girls for assays of serum lipid profiles after 3 mo of iron supplementation.
Venous blood (7 mL) was drawn into iron-free, evacuated, serum separator tubes after 12 h of fasting. CBC was measured with EDTA-anti-coagulated blood within 3 h after collection. Routine CBC and red cell indexes were determined with an electronic counter (SE 9000; Sysmex, Kobe, Japan). Serum iron, total iron-binding capacity (TIBC), and all lipid profiles were assayed with an automatic chemical analyzer (Hitachi 747; Hitachi, Tokyo, Japan). Serum ferritin was measured by the chemiluminescence method (ACS 180; Chiron, MA, USA) within 4 h after collection.
Serum concentrations of triglyceride, total cholesterol, and low- and high-density lipoprotein-cholesterol were analyzed by an enzymatic colorimetric method using triglyceride GPO-PAP reagents (Roche Diagnostics GmbH, Mannheim, Germany), SICDIA L T-CHO reagents (Eiken Chemical Industries, Tokyo, Japan), Cholestest-LDL reagents (Daiichi Chemicals, Tokyo, Japan), and Cholestest-HDL reagents (Daiichi Chemicals), respectively [1013].
Data analysis was performed using the SAS statistical computing software package (version 6.12 for Windows; SAS Institute, Inc., Cary, NC, USA). The Mann-Whitney U test was used to calculate the statistical significance of differences. The correlation between serum lipid concentrations and blood hemoglobin levels was assessed by Pearson correlation coefficients. All p values <0.01 were considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
12.0 g/dL), but there were no significant differences between these groups.
|
Table 2
also demonstrates the change in serum lipid concentrations in the girls with severe anemia after iron supplementation. Total cholesterol and triglyceride concentrations (164 ± 17 mg/dL and 98 ± 26 mg/dL, respectively) were significantly higher after iron supplementation, compared with the values (149 ± 17 mg/dL and 58 ± 22 mg/dL) before supplementation.
The correlations between hemoglobin levels and lipid profiles in severely anemic girls are shown in Figs. 2
and 3
. Blood Hb levels were correlated significantly with serum total cholesterol (r = 0.49, p <0.01) and triglyceride levels (r = 0.51, p < 0.01). No significant correlations were observed between serum HDL- or LDL-cholesterol concentrations and blood Hb values.
|
|
| Discussion |
|---|
|
|
|---|
El-Hazmi et al [18] reported that serum cholesterol levels were significantly lower in patients with sickle cell anemia compared to matched controls with normal hemoglobin levels. In our study, the serum total cholesterol concentration in subjects with moderate iron deficiency anemia did not differ significantly from healthy controls, although it tended to decrease as iron depletion progressed. However, our data showed that serum concentrations of total cholesterol and triglyceride were significantly lower in girls with severe anemia than in subjects with high hemoglobin levels. Our results are in accord with the previous studies in showing that severe iron deficiency affects lipid metabolism. On the basis of our results, we believe that the decreases in serum lipid concentrations are related to the severity of iron deficiency anemia.
Animal studies have indicated that lipid status may be influenced by dietary iron intake [19,20]. In our study, after iron supplementation, the initially reduced concentrations of total cholesterol and triglyceride returned to levels comparable to the healthy controls. These results are consistent with the reports of investigators [9,19] who demonstrated that dietary iron supplementation increases plasma lipids in rats. Obviously, it is difficult to compare such data from animal models with the present observations in young human females.
Ohira et al [19] found that total cholesterol concentrations were elevated following an increase in hemoglobin levels by transfusion and iron treatment. They also reported that the concentration of red blood cells might affect cholesterol synthesis or its mobilization from tissue to plasma. In contrast to these findings, Stangl and Kirchgessner [20] reported hypertriglyceridemia in rats receiving a very low level of dietary iron. On the other hand, Ece et al [21] found that iron deficiency itself has no direct effect on the lipid and lipoprotein profile. They suggested that an iron-deficient diet may be deficient in energy and protein, and that a hypocaloric diet could cause hypolipidemia. In the present study, only an iron tablet was given as a supplement, and no hypercaloric diet or vitamins were provided. Therefore, it appears that iron supplementation can elevate serum total cholesterol and triglyceride levels in girls with severe anemia caused by iron deficiency.
Relationships between hypocholesterolemia and anemia have been reported, and the effects of anemia on the development of atherosclerosis have been studied [2224]. Dabbagh et al [23] demonstrated that iron overload causes a significant increase in plasma total and HDL-cholesterol levels in rats. However, another of their studies [24] did not support the hypothesis that elevation of iron stores increases the risk of coronary artery disease.
Studies have shown a positive correlation between serum cholesterol level and hematocrit in healthy humans [25] and in anemic patients during iron supplementation [26]. El-Hazmi et al [18] reported a significant positive correlation between serum cholesterol and blood hemoglobin levels in patients with sickle cell anemia. In our study, blood hemoglobin levels correlated significantly with serum cholesterol concentrations, but only in girls with severe iron deficiency anemia.
Our data are in accord with the report of Ohira et al [19], who showed that in subjects with hemoglobin < 9.0 g/dL, there was a significant relationship between hemoglobin and cholesterol levels; this relationship was not seen in subjects with hemoglobin > 9.0 g/dL. They found that triglyceride levels were independent of blood hemoglobin levels. In contrast, in our study, blood hemoglobin levels correlated significantly with serum concentrations of triglyceride in girls with severe anemia. In our opinion, this discrepancy may be attributed to differences in the subjects. Our study only involved girls, age 1419 yr, who showed anemia with hemoglobin < 8.0 g/dL; this experimental design avoids the influences of gender, age, and occupations on serum lipid levels.
In conclusion, our results suggest that severe iron deficiency anemia in girls is attended by decreased serum concentrations of total cholesterol and triglyceride, and that these serum lipid abnormalities return to normal with iron supplementation.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. L. Sullivan Do Hemochromatosis Mutations Protect Against Iron-Mediated Atherogenesis? Circ Cardiovasc Genet, December 1, 2009; 2(6): 652 - 657. [Full Text] [PDF] |
||||
![]() |
J. L. Sullivan Letter by Sullivan Regarding Article, "HFE C282Y Homozygosity Is Associated With Lower Total and Low-Density Lipoprotein Cholesterol: the Hemochromatosis and Iron Overload Screening Study" Circ Cardiovasc Genet, June 1, 2009; 2(3): e1 - e1. [Full Text] [PDF] |
||||
![]() |
J. W. Choi, S. H. Pai, and S. K. Kim Associations Between Total Body Fat and Serum Lipid Concentrations in Obese Human Adolescents Ann. Clin. Lab. Sci., July 1, 2002; 32(3): 271 - 278. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |